Mill Creek Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Mill Creek Capital Advisors's LLY Position: Q1 2026 in Review
Mill Creek Capital Advisors increased its Eli Lilly (LLY) stake by 11% in Q1 2026, buying an estimated $61.8K and bringing the position to 614 shares worth $564K. The position accounts for 0.01% of the portfolio, ranked #154.
Mill Creek Capital Advisors first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.26M in Q2 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Mill Creek Capital Advisors held 614 shares of Eli Lilly worth $564K as of Q1 2026.
- Mill Creek Capital Advisors bought 61 Eli Lilly shares in Q1 2026, an estimated $61.8K.
- Eli Lilly made up 0.01% of Mill Creek Capital Advisors's portfolio in Q1 2026, its #154 holding.
- Mill Creek Capital Advisors first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
- Mill Creek Capital Advisors's Eli Lilly position peaked at $2.26M in Q2 2024.
- 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Mill Creek Capital Advisors's 13F filing for Q1 2026, filed 14 May 2026.